Evolution of the Average Target: Alcon Inc.

Evolution of the Target Price: Alcon Inc.

Changes in Analyst Recommendations: Alcon Inc.

53b7ca3a.B4qfHMxHOi4uyxFZOssxFVo3Q34xoc27TNtedC48_84.T8XlXqI_e3dH5l0gbpNGXRF8IAlY8LT_DrwoHGIKi5Fm2vFavQlyfmfyKQ~e15b8ff2cde26e884781bc2133963f47
08-17 Deutsche Bank raises TP for Alcon, but shares down Zonebourse
08-13 BNP Paribas Downgrades Alcon to Neutral, Cuts PT MT
08-13 Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2 MT
08-11 Alcon: Q2 story: Innovation is being well received by the end market Alphavalue
05-25 Baptista Research Upgrades Alcon to Buy Rating MT
05-13 Swiss Market Index Closes Higher; SoftwareOne Shares Jump MT
05-08 Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised MT
05-07 Needham Trims Price Target on Alcon to $95 From $100, Keeps Buy Rating MT
05-07 Alcon: Results weren't bad; today's correction is a buying opportunity Alphavalue
05-06 Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses MT
05-06 Swiss stocks - Factors to watch on May 6 RE
05-06 Alcon: Investment case hinges on profitability expansion Alphavalue
04-21 RBC Bullish on Alcon's FY26 Growth Outlook; Outperform Maintained MT
03-19 AlphaValue/Baader Europe Upgrades Alcon to Add Rating, Lifts PT MT
03-16 Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In MT
03-10 Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 MT
03-06 Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound MT
03-04 Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised MT
02-27 Equita SIM Upgrades Alcon to Buy, Raises PT MT
02-26 Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating MT
02-26 Wells Fargo Upgrades Alcon AG to Overweight From Equal Weight, Adjusts PT to $97 From $88 MT
02-26 Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up MT
02-26 Alcon: Markets forgive Q4 miss for a healthy 2026 outlook Alphavalue
02-18 RBC Updates Alcon Estimates Ahead of FY25 Earnings; Outperform Rating Kept MT
02-11 RBC Expects Alcon's Upcoming FY26 Guidance to Drive Share Price Volatility; Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+54.48%
+25.63%
+14.85%
+4.16%
+40.33%
+27.75%
+6.82%
+63.39%
+38.05%
Average +30.61%
Weighted average by Cap. +39.48%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
72.74USD
Average target price
91.39USD
Spread / Average Target
+25.63%
High Price Target
105.05USD
Spread / Highest target
+44.41%
Low Price Target
59.24USD
Spread / Lowest Target
-18.56%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA